We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-10.85%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.06B
AUM Growth
-$96.4M
Cap. Flow
+$61.7M
Cap. Flow %
5.81%
Top 10 Hldgs %
52.73%
Holding
288
New
112
Increased
38
Reduced
29
Closed
52

Sector Composition

Rank Sector Weight
1 Healthcare 51.62%
2 Financials 19.66%
3 Technology 5.66%
4 Industrials 4.81%
5 Materials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
76
Edwards Lifesciences
EW
$49.6B
$2.84M 0.27%
+25,083
New +$2.86M
ZBH icon
77
Zimmer Biomet
ZBH
$18.2B
$2.76M 0.26%
+19,406
New +$2.85M
PFG icon
78
Principal Financial Group
PFG
$24.3B
$2.74M 0.26%
+42,604
New +$2.74M
BHF icon
79
Brighthouse Financial
BHF
$3.56B
$2.74M 0.26%
+60,513
New +$2.73M
SYNA icon
80
Synaptics
SYNA
$4.19B
$2.72M 0.26%
+15,139
New +$2.55M
NARI
81
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.69M 0.25%
+33,198
New +$2.79M
DXCM icon
82
DexCom
DXCM
$32.2B
$2.64M 0.25%
+19,304
New +$2.43M
ABMD
83
CALL
DELISTED
Abiomed Inc
ABMD
$2.6M 0.24%
+8,000
New +$2.71M
SPB icon
84
Spectrum Brands
SPB
$2.04B
$2.6M 0.24%
+27,211
New +$2.31M
HWM icon
85
Howmet Aerospace
HWM
$113B
$2.59M 0.24%
+83,100
New +$2.68M
SCHW
86
Charles Schwab
SCHW
$183B
$2.57M 0.24%
+35,290
New +$2.52M
ORGO icon
87
Organogenesis Holdings
ORGO
$305M
$2.56M 0.24%
+180,082
New +$2.8M
PODD icon
88
Insulet
PODD
$11.5B
$2.5M 0.23%
+8,789
New +$2.51M
PL icon
89
Planet Labs
PL
$7.3B
$2.48M 0.23%
+250,000
New +$2.48M
EXPE icon
90
Expedia Group
EXPE
$35.4B
$2.34M 0.22%
14,300
-400
-3% -$61.8K
MTB icon
91
M&T Bank
MTB
$35.7B
$2.26M 0.21%
+15,107
New +$2.09M
AA icon
92
Alcoa
AA
$11.9B
$2.25M 0.21%
45,924
-113,174
-71% -$4.78M
BRO icon
93
Brown & Brown
BRO
$23.6B
$2.16M 0.2%
38,931
-77,553
-67% -$4.32M
BBL
94
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$2.13M 0.2%
+42,021
New +$2.53M
CBOE icon
95
Cboe Global Markets
CBOE
$32.5B
$2.12M 0.2%
17,146
-7,854
-31% -$959K
MT icon
96
ArcelorMittal
MT
$52.9B
$2.09M 0.2%
69,278
-136,722
-66% -$4.47M
QRVO icon
97
Qorvo
QRVO
$7.99B
$2.07M 0.19%
12,377
+1,377
+13% +$256K
WDC icon
98
Western Digital
WDC
$188B
$2.04M 0.19%
47,824
-22,652
-32% -$1.08M
SIGI icon
99
Selective Insurance
SIGI
$5.65B
$2M 0.19%
+26,465
New +$2.13M
HOLX
100
CALL
DELISTED
Hologic
HOLX
$1.87M 0.18%
+25,300
New +$1.9M

Similar funds

Crestline Management's Q3 2021 Portfolio in Review

As of Q3 2021, Crestline Management held 288 positions worth $1.06B, down 8.3% from $1.16B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Crestline Management deployed $61.7M of net new capital in Q3 2021, opening 112 new positions and adding to 38 existing holdings. Its largest new stake was Willis Towers Watson: 74,353 shares worth $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 62% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Denali Therapeutics, an estimated $24.3M trimmed.

  • Crestline Management's largest Q3 2021 buy was Willis Towers Watson: 74,353 shares worth $17.3M.
  • Crestline Management added most to Bank of America in Q3 2021, an estimated $9.77M increase.
  • Crestline Management's biggest Q3 2021 reduction was Denali Therapeutics, cutting an estimated $24.3M.
  • Crestline Management fully exited Petrobras Class A in Q3 2021, selling an estimated $25M.
  • Crestline Management's ten largest holdings make up 53% of its $1.06B portfolio in Q3 2021.
  • Crestline Management opened 112 new positions and closed 52 in Q3 2021.
  • Crestline Management's portfolio value fell 8.3% quarter-over-quarter to $1.06B.

Based on Crestline Management's 13F filing for Q3 2021, filed 12 Nov 2021.